Not checkedNot checked for notices yet.
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
Qingan Sun, Xiaojun Li, Lisa M. Perez and 3 more
Nature Communications · 2020
doi:10.1038/s41467-019-14238-3 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The important tuberculosis drug pyrazinamide (PZA) is converted to its active form pyrazinoic acid (POA) in Mycobacterium tuberculosis (Mtb). Here the authors identify the pantothenate biosynthesis pathway enzyme aspartate decarboxylase (PanD) as the target of PZA and determine the POA bound Mtb PanD crystal structure.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.